浏览全部资源
扫码关注微信
1.首都医科大学附属北京中医医院心血管科,北京 100010
2.首都医科大学,北京 100069
3.北京市中医药研究所脑心同治实验室,北京 100010
娄妍,女,29岁,博士研究生。研究方向:中医内科心血管病。
刘红旭,E-mail:lhx_@263.net
纸质出版日期:2024-11-25,
收稿日期:2024-03-04,
移动端阅览
娄妍,刘红旭,尚菊菊,等.参元益气活血胶囊对肿瘤坏死因子α诱导小鼠心肌细胞损伤的影响及机制[J].北京中医药,2024,43(11):1275-1280.
LOU Yan,LIU Hongxu,SHANG Juju,et al.Effect and mechanism of Shenyuan Yiqi Huoxui Capsules on TNF-α-induced myocardial cell injury in mice[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(11):1275-1280.
娄妍,刘红旭,尚菊菊,等.参元益气活血胶囊对肿瘤坏死因子α诱导小鼠心肌细胞损伤的影响及机制[J].北京中医药,2024,43(11):1275-1280. DOI: 10.16025/j.1674-1307.2024.11.011.
LOU Yan,LIU Hongxu,SHANG Juju,et al.Effect and mechanism of Shenyuan Yiqi Huoxui Capsules on TNF-α-induced myocardial cell injury in mice[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(11):1275-1280. DOI: 10.16025/j.1674-1307.2024.11.011.
目的
2
探讨参元益气活血胶囊(SYYQ)对肿瘤坏死因子α(TNF-α)诱导的小鼠心肌细胞损伤的影响及机制。
方法
2
常规培养小鼠心肌细胞(HL-1细胞),并制备SYYQ含药血清。用0、10%、20%、50%的SYYQ含药血清干预HL-1细胞,用细胞计数试剂法(CCK-8)检测细胞存活率,根据细胞存活率筛选最佳实验浓度。将HL-1细胞随机分为3组,对照组加入DMEM培养,模型组用50 ng/mL的TNF-α刺激12 h诱导心肌损伤模型,SYYQ组在模型组基础上加入最佳实验浓度的含药血清,同步培养12 h。流式细胞术检测细胞凋亡,Real-time PCR检测细胞内核因子κB(NF-κB)、核苷酸结合寡聚域样受体蛋白3(NLRP3)、白细胞介素18(IL-18)mRNA表达,Western blotting法检测细胞内NF-κB、NLRP3、IL-18蛋白表达。
结果
2
不同浓度SYYQ含药血清干预的心肌细胞存活率分别为(53.32±5.70)%、(68.24±6.41)%、(92.62±8.56)%、(86.93±7.12)%,故将20%含药血清组作为药物干预细胞的最佳浓度。对照组、模型组、SYYQ组心肌细胞凋亡率分别为(1.57±0.18)%、(18.99±1.32)%、(6.76±0.38)%。与对照组比较,模型组心肌细胞凋亡率高(
P
<
0.01);与模型组比较,SYYQ组心肌细胞凋亡率低(
P
<
0.01)。与对照组比较,模型组细胞内NF-κB、NLRP3、IL-18 mRNA相对表达量高(
P
<
0.05,
P
<
0.01);与模型组比较,SYYQ组细胞内NF-κB、NLRP3、IL-18 mRNA相对表达量低(
P
<
0.01)。与对照组比较,模型组细胞内NLRP3、IL-18蛋白相对表达量高(
P
<
0.01);与模型组比较,SYYQ组细胞内NF-κB、NLRP3、IL-18蛋白相对表达量低(
P
<
0.05,
P
<
0.01)。
结论
2
SYYQ可能通过调控NF-κB/NLRP3/IL-18信号通路减轻TNF-α所致心肌细胞损伤。
Objective
2
To investigate the effect of Shenyuan Yiqi Huoxue Capsules (SYYQ) on tumor necrosis factor α (TNF-α)-induced myocardial cell injury in mice and its mechanism.
Methods
2
Mouse cardiomyocytes (HL-1 cells) were cultured routinely, and SYYQ-containing serum was prepared. HL-1 cells were treated with 0%, 10%, 20%, and 50% SYYQ-containing serum. Cell viability was measured using the cell counting kit-8 (CCK-8) assay, and the optimal experimental concentration was selected based on the cell survival rate. HL-1 cells were randomly divided into three groups: the control group, which was cultured with DMEM; the model group, which was stimulated with 50 ng/mL TNF-α for 12 h to induce myocardial injury; the SYYQ group, which was treated with the optimal concentration of drug-containing serum for 12 h. Flow cytometry was used to detect apoptosis, and real-time PCR was used to measure the mRNA expression levels of nuclear factor kappa B (NF-κB), nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3), and interleukin-18 (IL-18). Western blotting was used to detect the protein expression levels of NF-κB, NLRP3, and IL-18.
Results
2
The survival rates of myocardial cells were (53.32±5.70)%,(68.24±6.41)%,(92.62±8.56)%, and (86.93±7.12)%, respectively. The 20% drug-containing serum group was selected as the optimal concentration for drug intervention. The apoptosis rates of cardiomyocytes in the control group, model group, and SYYQ group were(1.57±0.18)%,(18.99±1.32)%,and(6.76±0.38)%, respectively. Compared with the control group, the apoptosis rate in the model group was significantly higher (
P
<
0.01). Compared with the model group, the apoptosis rate in the SYYQ group was significantly lower (
P
<
0.01). The mRNA expression levels of NF-κB, NLRP3, and IL-18 were significantly higher in the model group compared with the control group (
P
<
0.05). Compared with the model group, the mRNA expression levels of NF-κB, NLRP3, and IL-18 were significantly lower in the SYYQ group (
P
<
0.01). The relative protein expression levels of NLRP3 and IL-18 were significantly higher in the model group compared with the control group (
P
<
0.01). Compared with the model group, the relative protein levels of NF-κB, NLRP3, and IL-18 were significantly lower in the SYYQ group (
P
<
0.05,
P
<
0.01).
Conclusion
2
SYYQ may reduce TNF-α-induced myocardial cell injury by regulating the NF-κB/NLRP3/IL-18 signaling pathway.
参元益气活血胶囊心肌细胞肿瘤坏死因子α炎症损伤核因子κB核苷酸结合寡聚域样受体蛋白3白细胞介素18小鼠
Shenyuan Yiqi Huoxue Capsulescardiomyocytestumor necrosis factor αinflammatory injurynuclear factor κbnucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3interleukin 18mouse
WANG LM,ZHAO N,ZHANG J,et al.Tumor necrosis factor-alpha inhibits osteogenic differentiation of pre-osteoblasts by downregulation of EphB4 signaling via activated nuclear factor-kappaB signaling pathway[J].J Periodontal Res,2018,53(1):66-72.
NGO KA,KISHIMOTO K,DAVIS-TURAK J,et al.Dissecting the regulatory strategies of NF-κB RelA target genes in the inflammatory response reveals differential transactivation logics[J].Cell Rep,2020,30(8):2758-2775.
FAVERO G,FRANCO C,STACCHIOTTI A,et al.Sirtuin1 role in the melatonin protective effects against obesity-related heart injury[J]. Front Physiol, 2020,11:103.
牛芊, 邢文龙, 刘红旭. 益气逐瘀法治疗冠心病基础与临床研究进展[J]. 世界中医药,2018,13(8):1817-1821.
邢文龙,唐跃,刘红旭,等.益气逐瘀法对中华小型猪PMI模型氧化应激反应的影响[J].世界中医药,2016,11(3):402-406.
杨志海, 佟彤, 刘红旭,等. 体外心肌细胞缺氧/复氧模型损伤及参元丹干预的影响[J]. 世界中医药,2016,11(3):398-401.
张竹华,刘子豪,张大炜,等.参元益气活血胶囊治疗不稳定型心绞痛的效果及机制研究[J].北京中医药,2022,41(12):1364-1367.
李爱勇,刘红旭,李峙宝,等.参元丹对不稳定型心绞痛气虚血瘀证患者药物洗脱球囊介入术后炎症因子影响观察[J].北京中医药,2022,41(12):1430-1432.
刘冬平,廖磊,李蜀平,等.参元益气活血胶囊对大鼠心肌缺血再灌注损伤的影响[J].北京中医药,2022,41(2):132-135.
CEN W,CHEN Z,GU N,et al.Prevention of AMI induced ventricular remodeling:inhibitory effects of Heart-Protecting Musk Pill on IL-6 and TNF-Alpha[J]. Evid Based Complement Alternat Med, 2017:3217395.
KROWN KA,PAGE MT,NGUYEN C,et al.Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes.Involvement of the sphingolipid signaling cascade in cardiac cell death[J].J Clin Invest,1996,98(12):2854-2865.
CAO Y, LUO F, PENG J, et al. KMT2B-dependent RFK transcription activates the TNF-α/NOX2 pathway and enhances ferroptosis caused by myocardial ischemia-reperfusion[J]. J Mol Cell Cardiol, 2022,173:75-91.
刘熔,崔彦杰,宋金萍.Wnt/β-catenin信号通路在TNF-α诱导的心肌细胞损伤和凋亡中的作用研究[J].国际检验医学杂志,2023,44(8):920-926.
DOYAMA K,FUJIWARA H,FUKUMOTO M,et al.Tumour necrosis factor is expressed in cardiac tissues of patients with heart failure[J]. Int J Cardiol, 1996,54(3):217-225.
TORRE-AMIONE G,KAPADIA S,LEE J,et al.Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart[J].Circulation,1996,93(4):704-711.
LI W, LI Y, CHU Y, et al. PLCE1 promotes myocardial ischemia-reperfusion injury in H/R H9c2 cells and I/R rats by promoting inflammation[J]. Biosci Rep, 2019,39(7):BSR20181613.
LI Y,FEI L,WANG J,et al.Inhibition of miR-217 Protects Against Myocardial Ischemia-Reperfusion Injury Through Inactivating NF-κB and MAPK Pathways[J].Cardiovasc Eng Technol,2020,11(2):219-227.
WANG L, MA H, XUE Y, et al. Berberine inhibits the ischemia-reperfusion injury induced inflammatory response and apoptosis of myocardial cells through the phosphoinositide 3-kinase/RAC-α serine/threonine-protein kinase and nuclear factor-κB signaling pathways[J]. Exp Ther Med, 2018,15(2):1225-1232.
JAHNG JW, SONG E, SWEENEY G. Crosstalk between the heart and peripheral organs in heart failure[J]. Exp Mol Med, 2016,48(3):e217.
QIN Q, LIN N, HUANG H, et al. Ginsenoside Rg1 ameliorates cardiac oxidative stress and inflammation in streptozotocin-induced diabetic rats[J]. Diabetes Metab Syndr Obes, 2019,12:1091-1103.
SINGLA DK, JOHNSON TA, TAVAKOLI DZ.Exosome treatment enhances anti-inflammatory M2 macrophages and reduces inflammation-induced pyroptosis in doxorubicin-induced cardiomyopathy[J].Cells,2019,8(10):1224.
LU J, XU L, ZENG Z, et al. Normothermic ex vivo heart perfusion combined with melatonin enhances myocardial protection in rat donation after circulatory death hearts via inhibiting NLRP3 inflammasome-mediated pyroptosis[J]. Front Cell Dev Biol, 2021,9:733183.
ZHANG H,LIN J,SHEN Y,et al.Protective effect of crocin on immune checkpoint inhibitors-related myocarditis through inhibiting NLRP3 mediated pyroptosis in cardiomyocytes via NF-kappaB pathway[J].J Inflamm Res,2022,15:1653-1666.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构